Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 414, pseudogene (RNU6-414P) is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. As a pseudogene, RNU6-414P does not produce a functional protein or functional RNA product and is not known to be involved in canonical biological pathways[4][5]. U6 snRNA is a key component of the spliceosome and crucial for the splicing of pre-mRNA in eukaryotic nuclei[1][3], but pseudogenes like RNU6-414P generally lack biological function and are not considered therapeutic targets. There are many U6-derived pseudogenes in the genome, created via processes like retrotransposition, but these generally have no known role in disease, are not used as biomarkers or therapeutic targets, and are not associated with drug interactions[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 414, pseudogene (RNU6-414P).